Table 5.

Inflammatory cells count in dystrophic muscles pre- and at the end of 6-month prednisone therapy

	DMD Range (Mean ± SD)		BMD Range (Mean ± SD)		LGMD Range (Mean ± SD)
Inflammatory cells	Pre-treatment	Post-treatment	Pre-treatment	Post-treatment	Pre-treatment	Post-treatment
Total MICs (H&E)	23.2 ± 10.1	18.0 ± 6.0**	18.3 ± 5.5	18.3 ± 7.6	20.0 ± 7.5	20.7 ± 7.5
Lymphocytes (CD3 and CD20)	3.6 ± 1.7	2.7 ± 1.1	3.3 ± 2.1	3.7 ± 1.2	2.5 ± 2.1	4.0 ± 1.4
Hitiocytes (CD68)	12.4 ± 0.9	9.0 ± 3.4	12.3 ± 1.59.7 ± 4.2	13.0 ± 6.2	11.7 ± 4.5
Dendritic cells (CD35)	3.4 ± 0.5	1.8 ± 0.8**	2.2 ± 0.7	1.8 ± 0.6*	2.5 ± 0.7	1.5 ± 0.7

BMD, Becker muscular dystrophies; DMD, Duchenne muscular dystrophies; H&E, haematoxylin and eosin; LGMD, limb girdle muscular dystrophies, MIC, mononuclear inflammatory cell.

^*P < 0.05

^**P < 0.01

^***P < 0.001.